NeuroTechnology Investors
Overview
NeuroTechnology Investors (NTI) is a global investor network of physicians that identifies, invests in, and provides operational expertise to emerging medical technology companies. The group states it is not a traditional fund, but an investment vehicle in which physicians retain control and invest their clinical expertise alongside capital to accelerate development. It focuses on neuro-focused companies and other advancements in the medical device and digital health sectors.
Portfolio Companies
5
Website
themdadvantage.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Synchron | Nov 2025 | Series D | Co-investor |
| Tulavi Therapeutics | Dec 2021 | Series B | Co-investor |
| Basecamp Vascular | Dec 2023 | Series A | Co-investor |
| Radical Catheter Technologies | Jul 2024 | VC Round | Lead |
| Let's Get Proof | May 2023 | Early Funding | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is NeuroTechnology Investors based?
NeuroTechnology Investors is headquartered in Palo Alto, California, United States.
When was NeuroTechnology Investors founded?
Founding year information for NeuroTechnology Investors is not publicly available.
How many portfolio companies does NeuroTechnology Investors have?
NeuroTechnology Investors has 5 portfolio companies in Caplight's dataset.
What are some companies in NeuroTechnology Investors's portfolio?
Portfolio companies visible on Caplight include Synchron, Tulavi Therapeutics, Basecamp Vascular, Radical Catheter Technologies, Let's Get Proof.
What was NeuroTechnology Investors's most recent investment shown here?
NeuroTechnology Investors's most recent investment in this portfolio sample was in Synchron in 2025.
What sectors does NeuroTechnology Investors focus on?
NeuroTechnology Investors focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does NeuroTechnology Investors focus on?
NeuroTechnology Investors typically invests at the Mid stage.